The University of Queensland, Queensland Brain Institute, Queensland, Australia.
Am J Med Genet B Neuropsychiatr Genet. 2014 Apr;165B(3):254-60. doi: 10.1002/ajmg.b.32230. Epub 2014 Mar 29.
Disturbed sleep and disrupted circadian rhythms are a common feature of psychiatric disorders, and many groups have postulated an association between genetic variants in circadian clock genes and psychiatric disorders. Using summary data from the association analyses of the Psychiatric Genomics Consortia (PGC) for schizophrenia, bipolar disorder and major depressive disorder, we evaluated the evidence that common SNPs in genes encoding components of the molecular clock influence risk to psychiatric disorders. Initially, gene-based and SNP P-values were analyzed for 21 core circadian genes. Subsequently, an expanded list of genes linked to control of circadian rhythms was analyzed. After correcting for multiple comparisons, none of the circadian genes were significantly associated with any of the three disorders. Several genes previously implicated in the etiology of psychiatric disorders harbored no SNPs significant at the nominal level of P < 0.05, and none of the the variants identified in candidate studies of clock genes that were included in the PGC datasets were significant after correction for multiple testing. There was no evidence of an enrichment of associations in genes linked to control of circadian rhythms in human cells. Our results suggest that genes encoding components of the molecular clock are not good candidates for harboring common variants that increase risk to bipolar disorder, schizophrenia, or major depressive disorder.
睡眠障碍和昼夜节律紊乱是精神疾病的常见特征,许多研究小组假设昼夜节律钟基因中的遗传变异与精神疾病之间存在关联。我们使用精神疾病基因组学联盟(PGC)对精神分裂症、双相情感障碍和重度抑郁症的关联分析的汇总数据,评估了编码分子钟成分的常见 SNPs 是否影响精神疾病的风险。最初,对 21 个核心生物钟基因进行了基于基因和 SNP 的 P 值分析。随后,分析了与昼夜节律控制相关的基因的扩展列表。在进行多次比较校正后,没有一个生物钟基因与这三种疾病中的任何一种显著相关。先前与精神疾病病因学相关的几个基因中没有任何 SNP 在名义水平 P<0.05 上显著,并且在 PGC 数据集中包含的时钟基因候选研究中确定的变体在进行多次测试校正后也没有显著意义。在与人细胞中昼夜节律控制相关的基因中没有发现关联富集的证据。我们的研究结果表明,编码分子钟成分的基因不是携带增加双相情感障碍、精神分裂症或重度抑郁症风险的常见变异的良好候选基因。